Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Xylem to Release Second Quarter 2026 Financial Results on July 28, 2026
-
Ryan Specialty to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
-
RenaissanceRe Schedules Second Quarter 2026 Financial Results Conference Call
-
Kite Realty Group Announces Closing of Offering of 3.25% Exchangeable Senior Notes due 2032
-
Kite Realty Group Announces Closing of Offering of 3.25% Exchangeable Senior Notes due 2032
-
Piedmont Realty Trust, Inc. to Report Second Quarter 2026 Financial Results
-
South Coast AQMD Expands Air Purifier Program for Communities Near the Palos Fire
-
First Trust Announces Changes to Investment Strategies, Name and Other Related Matters for First Trust RiverFront Dynamic Developed International ETF
-
First Trust Announces Changes to Investment Strategies, Name and Other Related Matters for First Trust RiverFront Dynamic Emerging Markets ETF
-
Broadstone Net Lease Schedules Second Quarter 2026 Earnings Release and Conference Call
-
Canadian Gold Resources Announces Cancellation of LIFE Offering
-
In HelloNation, Dental Expert Richard D. Byler, DDS Discusses Tooth Pain, Cavities, & Root Canal Treatment
-
REVER Launches Million Mile Challenge Supporting Pediatric Brain Tumor Foundation
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2026 Earnings Call
-
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
-
Kinsale Capital Group Announces Second Quarter 2026 Earnings Release Date and Conference Call
-
AXT, Inc. Schedules Second Quarter 2026 Earnings Release for July 30, 2026
-
Acadia Realty Trust to Announce Second Quarter 2026 Earnings on July 28, 2026
-
Net Asset Value Restatement for Simplify Barrier Income ETF (SBAR)
-
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
-
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
NETSTREIT Corp. Announces Dates for Second Quarter 2026 Earnings Release and Conference Call
-
Terex Announces Quarterly Dividend
-
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
-
Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Thursday, July 16, 2026
-
Block to Announce Second Quarter 2026 Results
-
Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss Its Second Quarter Ended June 30, 2026 Financial Results
-
MGIC Investment Corporation Schedules 2nd Quarter 2026 Earnings Call
-
Patria Investments successfully raises over USD 670m for its Secondary Opportunities Fund V
-
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Robinhood Markets, Inc. to Announce Second Quarter 2026 Results on July 29, 2026
-
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Ryerson to Host Earnings Call on Thursday, July 30th to Discuss Second Quarter 2026 Results
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
-
Scholastic Corporation Announces Date for Fourth Quarter and Fiscal 2026 Earnings Release and Conference Call
-
STANDEX ACQUIRES REMAINING INTEREST IN NARAYAN POWERTECH
-
Presidio Closes Canyon Creek Acquisition
-
POSaBIT Announces Results of Annual and Special Meeting of Shareholders
-
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
XFoil Launches a Direct-to-Consumer eFoil Line, Undercutting the $15,000 Industry Pricing by More Than Half
